Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD
12.48
-0.83 (-6.24%)
May 7, 2026, 4:08 PM HKT
HKG:2591 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| -341.36 | -174.69 | -733.38 |
Depreciation & Amortization | 9.4 | 16.76 | 19.54 |
| 0.58 | 0.17 | 0.1 |
Loss (Gain) From Sale of Assets | - | 0.3 | - |
Loss (Gain) From Sale of Investments | - | -0.19 | -1.13 |
| 14.96 | 16.04 | 538.9 |
Other Operating Activities | -1.59 | -12.58 | -8.43 |
Change in Accounts Receivable | -5.56 | - | - |
| -86.91 | -25.59 | 0.23 |
Change in Accounts Payable | 134.04 | 2.71 | 15.64 |
Change in Other Net Operating Assets | -19.09 | 14.46 | 3.92 |
| -295.54 | -162.62 | -164.6 |
| -19.97 | -3.95 | -12.05 |
Sale (Purchase) of Intangibles | -2.06 | -0.38 | -0.15 |
| 44.66 | 280.28 | -145.02 |
| 22.63 | 275.95 | -157.21 |
| 172.76 | 9.9 | 1 |
| 172.76 | 9.9 | 1 |
| -32.4 | -1 | -1 |
| -1.91 | -0.81 | -4.45 |
| -34.31 | -1.81 | -5.45 |
| 138.45 | 8.1 | -4.45 |
| 621.78 | 250 | 367.81 |
Other Financing Activities | -37.87 | -3.26 | -11.66 |
| 722.37 | 254.84 | 351.71 |
Foreign Exchange Rate Adjustments | -6.89 | 0.7 | 0.71 |
| 442.58 | 368.87 | 30.61 |
| -315.51 | -166.57 | -176.64 |
| -239.91% | - | - |
| -0.73 | -0.40 | -0.46 |
| 1.72 | 0.87 | 2.32 |
| -224.14 | -95.73 | - |
| -223.06 | -95.18 | - |
Change in Working Capital | 22.48 | -8.41 | 19.79 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.